{"id":285,"date":"2025-06-16T19:08:56","date_gmt":"2025-06-16T19:08:56","guid":{"rendered":"http:\/\/liminal.miara.co.uk\/?page_id=285"},"modified":"2025-09-09T11:29:31","modified_gmt":"2025-09-09T11:29:31","slug":"produits-candidat","status":"publish","type":"page","link":"https:\/\/liminalbiosciences.com\/fr\/produits-candidat\/","title":{"rendered":"Produits Candidats"},"content":{"rendered":"<div class=\"title-block\"><div id=\"top-bg\" class=\"small\">\n\t<img decoding=\"async\" src=\"https:\/\/liminalbiosciences.com\/wp-content\/themes\/liminal\/images\/top-bg.png\" \/>\n<\/div>\n<div class=\"cont\">\n    <h1>Produits Candidat<\/h1><\/div><\/div>\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<div class=\"cont paragraph\" data-scroll><p> Nous disposons de trois programmes de produits candidats \u00e0 petites mol\u00e9cules bas\u00e9s sur les RCPG ciblant les maladies m\u00e9taboliques, inflammatoires et fibrotiques: <\/p><\/div>\n<\/div>\n<\/div>\n\n\n<div class=\"pipeline-block\"><script>\n    jQuery.fn.isInViewport = function() {\n        var elementTop = jQuery(this).offset().top;\n        var elementBottom = elementTop + jQuery(this).outerHeight();\n\n        var viewportTop = jQuery(window).scrollTop();\n        var viewportBottom = viewportTop + jQuery(window).height();\n\n        return elementBottom > viewportTop && elementTop < viewportBottom;\n    };\n    jQuery(window).on('resize scroll load', function() {\n        if (jQuery('#pl').isInViewport()) {\n            setTimeout(function() {\n                jQuery('#pl').addClass('anim');\n            }, 100);\n        }\n    });\n<\/script>\n\n\n<div id=\"pl\"> \n    <div class=\"pl-header\">\n        <div class=\"info\">\n            <div class=\"\">Droits<br>Mondiaux<\/div>\n            <div class=\"\">Programme<\/div>\n            <div class=\"\">Indications<br>Potentielles<\/div>\n        <\/div>\n        <div class=\"phase\">\n            <div class=\"col\">\n                <div class=\"title\">Pr\u00e9clinique<\/div>\n                <div class=\"col\">\n                    <div class=\"\">D\u00e9couverte<\/div>\n                    <div class=\"\">Optimisation<\/div>\n                    <div class=\"\">Pr\u00e9paration pour la demande d\u2019essai clinique<\/div>\n                <\/div>\n            <\/div>\n            <div class=\"col\">\n                <div class=\"title\">Clinique<\/div>\n                <div class=\"col\">\n                    <div class=\"\">Phase 1<\/div>\n                    <div class=\"\">Phase 2<\/div>\n                    <div class=\"\">Phase 3<\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n        <div class=\"milestones\">\n            Jalons Pr\u00e9vus        <\/div>\n    <\/div>\n\n    <div class=\"pl-body\"><div class=\"bars\"><div class=\"s1\"><\/div><div class=\"s2\"><span><\/span><span><\/span><span><\/span><span><\/span><span><\/span><\/div><div class=\"s3\"><\/div><\/div><div class=\"product\"><div class=\"info\"><div class=\"col logo liminal\"><\/div><div class=\"col program\"><span>Antagoniste du GPR84<\/span><\/div><div class=\"col indicator\"><ul><li>Maladies m\u00e9taboliques<\/li><li>St\u00e9atose h\u00e9patique non-alcoolique<\/li><\/ul><\/div><\/div><div class=\"phase\"><div class=\"phase-bar phase-5\"><\/div><\/div><div class=\"milestones\"><span><p class=\"p1\"><span style=\"font-weight: 400;\">\u00c9tude Clinique de <strong>Phase 1b<\/strong> r\u00e9cemment commenc\u00e9e<\/span><\/p>\n<\/span><\/div><\/div><div class=\"product\"><div class=\"info\"><div class=\"col logo liminal\"><\/div><div class=\"col program\"><span>Antagoniste du OXER1<\/span><\/div><div class=\"col indicator\"><ul><li>L\u2019asthme \u00e9osinophilique<\/li><li>Dermatite atopique<\/li><\/ul><\/div><\/div><div class=\"phase\"><div class=\"phase-bar phase-2\"><\/div><\/div><div class=\"milestones\"><span><p class=\"p1\"><span style=\"font-weight: 400;\">Candidat pr\u00e9clinique d\u00e9sign\u00e9<\/span><\/p>\n<\/span><\/div><\/div><div class=\"product\"><div class=\"info\"><div class=\"col logo liminal\"><\/div><div class=\"col program\"><span>Agoniste du GPR40<\/span><\/div><div class=\"col indicator\"><ul><li>R\u00e9sistance \u00e0 l\u2019insuline \/ Diab\u00e8te<\/li><\/ul><\/div><\/div><div class=\"phase\"><div class=\"phase-bar phase-1\"><\/div><\/div><div class=\"milestones\"><span><p><span style=\"font-weight: 400;\">Phase de D\u00e9couverte<\/span><\/p>\n<\/span><\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Nous disposons de trois programmes de produits candidats \u00e0 petites mol\u00e9cules bas\u00e9s sur les RCPG ciblant les maladies m\u00e9taboliques, inflammatoires et fibrotiques:<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-285","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/liminalbiosciences.com\/fr\/wp-json\/wp\/v2\/pages\/285","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/liminalbiosciences.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/liminalbiosciences.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/liminalbiosciences.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/liminalbiosciences.com\/fr\/wp-json\/wp\/v2\/comments?post=285"}],"version-history":[{"count":3,"href":"https:\/\/liminalbiosciences.com\/fr\/wp-json\/wp\/v2\/pages\/285\/revisions"}],"predecessor-version":[{"id":332,"href":"https:\/\/liminalbiosciences.com\/fr\/wp-json\/wp\/v2\/pages\/285\/revisions\/332"}],"wp:attachment":[{"href":"https:\/\/liminalbiosciences.com\/fr\/wp-json\/wp\/v2\/media?parent=285"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}